company background image
CTVA

CortevaNYSE:CTVA Stock Report

Last Price

US$46.05

Market Cap

US$33.6b

7D

-4.3%

1Y

16.6%

Updated

25 Jan, 2022

Data

Company Financials +
CTVA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance5/6
Financial Health5/6
Dividends2/6

CTVA Stock Overview

Corteva, Inc. operates in the agriculture business.

Corteva Competitors

FMC

NYSE:FMC

US$13.6b

Bioceres Crop Solutions

NasdaqGS:BIOX

US$530.7m

Marrone Bio Innovations

NasdaqCM:MBII

US$116.3m

Saudi Basic Industries

SASE:2010

ر.س372.6b

Price History & Performance

Summary of all time highs, changes and price drops for Corteva
Historical stock prices
Current Share PriceUS$46.05
52 Week HighUS$49.98
52 Week LowUS$36.54
Beta0.79
1 Month Change-0.84%
3 Month Change9.36%
1 Year Change16.64%
3 Year Changen/a
5 Year Changen/a
Change since IPO85.61%

Recent News & Updates

Jan 19
Corteva's (NYSE:CTVA) Returns On Capital Not Reflecting Well On The Business

Corteva's (NYSE:CTVA) Returns On Capital Not Reflecting Well On The Business

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Dec 26
Is Corteva (NYSE:CTVA) A Risky Investment?

Is Corteva (NYSE:CTVA) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Dec 06
Here's Why We Think Corteva (NYSE:CTVA) Is Well Worth Watching

Here's Why We Think Corteva (NYSE:CTVA) Is Well Worth Watching

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Nov 26
Corteva, Inc. (NYSE:CTVA) Shares Could Be 30% Below Their Intrinsic Value Estimate

Corteva, Inc. (NYSE:CTVA) Shares Could Be 30% Below Their Intrinsic Value Estimate

Does the November share price for Corteva, Inc. ( NYSE:CTVA ) reflect what it's really worth? Today, we will estimate...

Nov 05

The Momentum Investor: Spotlight On Corteva

Industrial fundamentals are strong. The company has delivered four consecutive earnings beats. The stock has had two solid days of gains on strong volume.

Shareholder Returns

CTVAUS ChemicalsUS Market
7D-4.3%-6.0%-5.8%
1Y16.6%10.1%4.2%

Return vs Industry: CTVA exceeded the US Chemicals industry which returned 10.1% over the past year.

Return vs Market: CTVA exceeded the US Market which returned 4.2% over the past year.

Price Volatility

Is CTVA's price volatile compared to industry and market?
CTVA volatility
CTVA Average Weekly Movement3.9%
Chemicals Industry Average Movement5.7%
Market Average Movement6.7%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.4%

Stable Share Price: CTVA is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CTVA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a21,000Chuck Magrohttps://www.corteva.com

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms.

Corteva Fundamentals Summary

How do Corteva's earnings and revenue compare to its market cap?
CTVA fundamental statistics
Market CapUS$33.58b
Earnings (TTM)US$1.76b
Revenue (TTM)US$15.38b

19.1x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CTVA income statement (TTM)
RevenueUS$15.38b
Cost of RevenueUS$9.10b
Gross ProfitUS$6.28b
ExpensesUS$4.53b
EarningsUS$1.76b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

Feb 03, 2022

Earnings per share (EPS)2.41
Gross Margin40.84%
Net Profit Margin11.42%
Debt/Equity Ratio9.9%

How did CTVA perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

23%

Payout Ratio

Valuation

Is Corteva undervalued compared to its fair value and its price relative to the market?

32.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CTVA ($46.05) is trading below our estimate of fair value ($68.22)

Significantly Below Fair Value: CTVA is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CTVA is good value based on its PE Ratio (19.1x) compared to the US Chemicals industry average (20.5x).

PE vs Market: CTVA is poor value based on its PE Ratio (19.1x) compared to the US market (16.5x).


Price to Earnings Growth Ratio

PEG Ratio: CTVA is poor value based on its PEG Ratio (1.6x)


Price to Book Ratio

PB vs Industry: CTVA is good value based on its PB Ratio (1.4x) compared to the US Chemicals industry average (2.4x).


Future Growth

How is Corteva forecast to perform in the next 1 to 3 years based on estimates from 18 analysts?

12.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CTVA's forecast earnings growth (12.1% per year) is above the savings rate (2%).

Earnings vs Market: CTVA's earnings (12.1% per year) are forecast to grow slower than the US market (13% per year).

High Growth Earnings: CTVA's earnings are forecast to grow, but not significantly.

Revenue vs Market: CTVA's revenue (4.7% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: CTVA's revenue (4.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CTVA's Return on Equity is forecast to be low in 3 years time (8%).


Past Performance

How has Corteva performed over the past 5 years?

20.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CTVA has high quality earnings.

Growing Profit Margin: CTVA's current net profit margins (11.4%) are higher than last year (4.2%).


Past Earnings Growth Analysis

Earnings Trend: CTVA has become profitable over the past 5 years, growing earnings by 20.5% per year.

Accelerating Growth: CTVA's earnings growth over the past year (195.6%) exceeds its 5-year average (20.5% per year).

Earnings vs Industry: CTVA earnings growth over the past year (195.6%) exceeded the Chemicals industry 17.5%.


Return on Equity

High ROE: CTVA's Return on Equity (7.1%) is considered low.


Financial Health

How is Corteva's financial position?


Financial Position Analysis

Short Term Liabilities: CTVA's short term assets ($14.1B) exceed its short term liabilities ($7.8B).

Long Term Liabilities: CTVA's short term assets ($14.1B) exceed its long term liabilities ($8.3B).


Debt to Equity History and Analysis

Debt Level: CTVA has more cash than its total debt.

Reducing Debt: Insufficient data to determine if CTVA's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: CTVA's debt is well covered by operating cash flow (100.4%).

Interest Coverage: CTVA earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Corteva current dividend yield, its reliability and sustainability?

1.22%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CTVA's dividend (1.22%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.36%).

High Dividend: CTVA's dividend (1.22%) is low compared to the top 25% of dividend payers in the US market (3.57%).


Stability and Growth of Payments

Stable Dividend: Whilst dividend payments have been stable, CTVA has been paying a dividend for less than 10 years.

Growing Dividend: CTVA's dividend payments have increased, but the company has only paid a dividend for 3 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (22.8%), CTVA's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CTVA's dividends in 3 years are forecast to be well covered by earnings (20% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.7yrs

Average management tenure


CEO

Chuck Magro (51 yo)

0.17

Tenure

Mr. Charles Victor Magro, also known as Chuck, B.Sc. (Chem), MBA serves as Chief Executive Officer and Director for Corteva, Inc. since November 1, 2021. He had served as the President and Chief Executive...


Leadership Team

Experienced Management: CTVA's management team is considered experienced (2.7 years average tenure).


Board Members

Experienced Board: CTVA's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CTVA insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Corteva, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Corteva, Inc.
  • Ticker: CTVA
  • Exchange: NYSE
  • Founded: NaN
  • Industry: Fertilizers and Agricultural Chemicals
  • Sector: Materials
  • Implied Market Cap: US$33.581b
  • Shares outstanding: 728.91m
  • Website: https://www.corteva.com

Number of Employees


Location

  • Corteva, Inc.
  • Chestnut Run Plaza 735
  • PO Box 80735
  • Wilmington
  • Delaware
  • 19805-0735
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/25 23:06
End of Day Share Price2022/01/25 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.